Liminal BioSciences Inc reports results for the quarter ended in March - Earnings Summary

Liminal BioSciences

17/05/2021 23:35

* Liminal BioSciences Inc  LMNL.OQ  reported a quarterly
adjusted loss of 68 cents​​ per share for the quarter ended
in March. The mean expectation of two analysts for the quarter
was for a loss of 63 cents per share.
* Revenue was C$210.00 thousand​;  analysts expected C$932.00
thousand. 
* Liminal BioSciences Inc's reported EPS for the quarter was a
loss of 68 cents​.
* The mean earnings estimate of analysts had risen by about 6%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Liminal BioSciences Inc shares had risen by 3.6% this
quarter and gained 1.9% so far this year.
* The company reported a quarterly loss of C$20.85 million.
* Wall Street's median 12-month price target for Liminal
BioSciences Inc is $7.50 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated May 17 at 10:34 p.m. GMT.
​All figures in Canadian dollars